Inactive Instrument
Canntab Therapeutics Limited Stock
Stocks
CTABF
CA1377991023
Pharmaceuticals
OTC Markets Traded| 1 day | -99.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | - | 2020-05-14 | |
Frank Candido
IRC | Investor Relations Contact | 61 | 2018-08-31 |
Eric Malinski
SAM | Sales & Marketing | - | 2018-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/6/24 | Option | Director | 100,000 | 0.2570% | ||
| 2/6/24 | Option | Director | 100,000 | 0.2570% | ||
| 2/22/22 | Sell | Chief Executive Officer | 400,000 | 1.0717% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -99.00% | -.--% | - | - | 38 | |
| -0.70% | -2.79% | -9.05% | -6.89% | 13.54B | |
| -0.81% | -3.21% | +4.93% | +2.37% | 5.11B | |
| -0.99% | -4.67% | -31.60% | -56.22% | 5.11B | |
| -0.12% | +0.90% | +5.57% | -29.80% | 4.18B | |
| -1.13% | -2.80% | -7.89% | -5.93% | 3.69B | |
| -0.93% | -4.47% | -3.06% | +3.55% | 3.54B | |
| -0.64% | -2.33% | -3.66% | +15.21% | 3.46B | |
| -0.44% | -1.00% | -12.80% | -15.78% | 2.48B | |
| +0.71% | -2.34% | -2.38% | +44.27% | 1.87B | |
| Average | -10.41% | -0.33% | -6.66% | -5.47% | 4.78B | |
| Weighted average by Cap. | -0.67% | -0.34% | -7.55% | -9.45% |
Employees
-
Sector
Pharmaceuticals
